Overview
Partial duplication/triplication of chromosome 5 syndrome (Orphanet code 262211) refers to a group of rare chromosomal anomalies in which a segment of chromosome 5 is present in extra copies — either duplicated (resulting in three copies of that segment) or triplicated (resulting in four copies). The clinical presentation is highly variable and depends on the size and specific location of the duplicated or triplicated region along chromosome 5, as well as whether the rearrangement is de novo or inherited. Because chromosome 5 contains numerous genes involved in development, these extra copies can disrupt normal growth and organ formation. Affected individuals may present with intellectual disability, developmental delay, growth abnormalities, dysmorphic facial features, and congenital malformations involving multiple organ systems including the heart, brain, kidneys, and skeletal system. Hypotonia, feeding difficulties in infancy, and speech and language delays are also commonly reported. The severity of symptoms can range from mild learning difficulties to significant multi-system involvement depending on the specific chromosomal segment involved. For example, duplications involving the proximal long arm (5q) may have different clinical consequences than those involving the short arm (5p). There is no specific cure or targeted therapy for partial duplication or triplication of chromosome 5. Management is supportive and symptom-based, typically involving a multidisciplinary team including pediatricians, geneticists, cardiologists, neurologists, and developmental specialists. Early intervention programs addressing speech, occupational, and physical therapy are important components of care. Genetic counseling is recommended for affected families to assess recurrence risk, particularly when a parent carries a balanced chromosomal rearrangement that predisposes to unbalanced offspring.
Also known as:
Variable
Can be inherited in different ways depending on the underlying gene
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Partial duplication/triplication of chromosome 5 syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Partial duplication/triplication of chromosome 5 syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Partial duplication/triplication of chromosome 5 syndrome.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Partial duplication/triplication of chromosome 5 syndrome.
Community
No community posts yet. Be the first to share your experience with Partial duplication/triplication of chromosome 5 syndrome.
Start the conversation →Latest news about Partial duplication/triplication of chromosome 5 syndrome
No recent news articles for Partial duplication/triplication of chromosome 5 syndrome.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Partial duplication/triplication of chromosome 5 syndrome
What is Partial duplication/triplication of chromosome 5 syndrome?
Partial duplication/triplication of chromosome 5 syndrome (Orphanet code 262211) refers to a group of rare chromosomal anomalies in which a segment of chromosome 5 is present in extra copies — either duplicated (resulting in three copies of that segment) or triplicated (resulting in four copies). The clinical presentation is highly variable and depends on the size and specific location of the duplicated or triplicated region along chromosome 5, as well as whether the rearrangement is de novo or inherited. Because chromosome 5 contains numerous genes involved in development, these extra copies
At what age does Partial duplication/triplication of chromosome 5 syndrome typically begin?
Typical onset of Partial duplication/triplication of chromosome 5 syndrome is neonatal. Age of onset can vary across affected individuals.